Atherosclerotic cardiovascular disease risk difference in metabolic dysfunction-associated fatty liver disease and nonalcoholic fatty liver disease

被引：3
|
作者：
Tamaki, Nobuharu [1 ]
Kurosaki, Masayuki [1 ]
Higuchi, Mayu [1 ]
Izumi, Namiki [1 ]
机构：
[1] Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, 1-26-1 Kyonancho, Musashino, Tokyo 1808610, Japan
来源：
HEPATOLOGY RESEARCH | 2021年 / 51卷 / 11期
关键词：
cardiovascular disease (CVD); liver fibrosis; metabolic dysfunction associated fatty liver disease (MAFLD); nonalcoholic fatty liver disease (NAFLD);
D O I：
10.1111/hepr.13700
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1172 / 1173
页数：2
相关论文
共 50 条
  • [1] Metabolic Dysfunction-Associated Fatty Liver Disease, Statins, and Atherosclerotic Cardiovascular Disease
    Chang, Hui-Chin
    Gau, Shuo-Yan
    [J]. AMERICAN JOURNAL OF MEDICINE, 2024, 137 (01): : E14 - E14
  • [2] Metabolic dysfunction-associated fatty liver disease and atherosclerotic cardiovascular disease risk: Dual aetiology or metabolic dysfunction?
    Ma, Tianyi
    Yuan, Huawei
    Guo, Zhanfang
    [J]. LIVER INTERNATIONAL, 2024,
  • [3] Metabolic Dysfunction-Associated Fatty Liver Disease, Statins, and Atherosclerotic Cardiovascular Disease Reply
    Yeoh, Aaron
    Cheung, Ramsey
    Ahmed, Aijaz
    Chitnis, Amit S.
    Do, Albert
    Wong, Robert J.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2024, 137 (01): : E15 - E15
  • [4] Transition of an acronym from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease
    Shahinul Alam
    Shah Mohammad Fahim
    [J]. World Journal of Hepatology, 2021, 13 (10) : 1203 - 1207
  • [5] Transition of an acronym from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease
    Alam, Shahinul
    Fahim, Shah Mohammad
    [J]. WORLD JOURNAL OF HEPATOLOGY, 2021, 13 (10) : 1203 - 1207
  • [6] Metabolic dysfunction-associated fatty liver disease and nonalcoholic fatty liver disease: Which can better identify the populations with a high risk of cardiovascular disease?
    Yoshio, Sachiyo
    [J]. HEPATOLOGY RESEARCH, 2021, 51 (11) : 1097 - 1099
  • [7] Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention
    Xiao-Dong Zhou
    Jingjing Cai
    Giovanni Targher
    Christopher D. Byrne
    Michael D. Shapiro
    Ki-Chul Sung
    Virend K. Somers
    C. Anwar A. Chahal
    Jacob George
    Li-Li Chen
    Yong Zhou
    Ming-Hua Zheng
    [J]. Cardiovascular Diabetology, 21
  • [8] Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention
    Zhou, Xiao-Dong
    Cai, Jingjing
    Targher, Giovanni
    Byrne, Christopher D.
    Shapiro, Michael D.
    Sung, Ki-Chul
    Somers, Virend K.
    Chahal, C. Anwar A.
    George, Jacob
    Chen, Li-Li
    Zhou, Yong
    Zheng, Ming-Hua
    [J]. CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [9] Concordance between metabolic dysfunction-associated steatotic liver disease and nonalcoholic fatty liver disease
    Suzuki, Keito
    Tamaki, Nobuharu
    Kurosaki, Masayuki
    Takahashi, Yuka
    Yamazaki, Yudai
    Uchihara, Naoki
    Tanaka, Yuki
    Miyamoto, Haruka
    Yamada, Michiko
    Keitoku, Taisei
    Okada, Risa
    Higuchi, Mayu
    Takaura, Kenta
    Tanaka, Shohei
    Maeyashiki, Chiaki
    Yasui, Yutaka
    Tsuchiya, Kaoru
    Nakanishi, Hiroyuki
    Izumi, Namiki
    [J]. HEPATOLOGY RESEARCH, 2024, 54 (06) : 600 - 605
  • [10] Nonalcoholic fatty liver disease or metabolic dysfunction-associated fatty liver disease diagnoses and cardiovascular diseases: From epidemiology to drug approaches
    Dongiovanni, Paola
    Paolini, Erika
    Corsini, Alberto
    Sirtori, Cesare R.
    Ruscica, Massimiliano
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2021, 51 (07)
12345